Skip to content

Work sustainability and symptoms of breast cancer survivors receiving endocrine therapy

Work sustainability and symptoms of breast cancer survivors receiving endocrine therapy - Work sustainability and symptoms of breast cancer survivors receiving endocrine therapy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000036742
Enrollment
140
Registered
2019-05-15
Start date
2019-05-15
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

None listed

Sponsors

Keio University Graduate School of Health Management
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1)diagnosed with breast cancer 2)aged from 20 to 64 3)receiving endocrine therapy for more than 3 months and less than 5 years following surgery, chemotherapy, targeted therapy, radiation therapy as necessary 4)able to communicate in Japanese and complete a questionnaire 5)who understands the purpose of this study and agrees to participate

Exclusion criteria

Exclusion criteria: 1)with metastasis or recurrence 2)with a history of cognitive/ mental disorder prior to the diagnosis of cancer 3)no longer working because of other health problems

Design outcomes

Primary

MeasureTime frame
Work sustainability(work status at the time of diagnosis and present)

Secondary

MeasureTime frame
Work productivity and activity impairment (overall work impairment) Symptoms Work support

Countries

Japan

Contacts

Public ContactMayumi Nakao

Keio University Graduate School of Health Management Nursing

mayumina@sfc.keio.ac.jp0466-49-6265

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026